HF4124

Manufacturers prohibited from advertising prescription drugs on television.
Legislative Session 94 (2025-2026)

Related bill: SF3650

AI Generated Summary

Purpose

  • This bill aims to restrict how prescription drugs can be marketed in Minnesota by banning televised advertising that promotes the direct sale of prescription drugs to consumers.

Definitions

  • Manufacturer: A drug manufacturer licensed under section 151.252.
  • Prescription drug: A drug defined as a prescription drug under section 151.441 subdivision 8.

Prohibition

  • A manufacturer is prohibited from using televised advertisements to advertise the direct sale of prescription drugs to consumers.

Enforcement

  • The attorney general may enforce this prohibition under section 8.31 of Minnesota law.

Legal Status and Scope

  • The bill creates a new provision codified in Minnesota Statutes, chapter 325F (pharmaceutical advertising), specifically adding a new section 325F.7845.

Significance and Potential Impact

  • Limits direct-to-consumer prescription drug advertising on television by manufacturers.
  • Does not appear to restrict other advertising channels (e.g., online, print) unless further provisions exist.
  • Enforcement would be handled by the state Attorney General; no penalties are specified in the excerpt.

Relevant Terms - manufacturer - drug manufacturer licensed under section 151.252 - prescription drug - televised advertisements - direct sale of prescription drugs to consumers - Minnesota Statutes chapter 325F - 325F.7845 - Attorney General - section 8.31

Bill text versions

Showing the most recent version. There are  1  total versions. You must be logged in  to view additional bill text versions.

Actions

DateChamberWhereTypeNameCommittee Name
March 09, 2026HouseActionIntroduction and first reading, referred toCommerce Finance and Policy
March 12, 2026HouseActionAuthor added
March 18, 2026HouseActionAuthor added
Showing the 5  most recent stages. This bill has 3  stages in total. Log in to view all stages

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee

Sponsors

You must be logged in  to view sponsors.

Loading…